Related Experiment Video
Updated: Jul 20, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
Published on: February 28, 2025
Experience with choledochal cysts in infants
Paari Vijayaraghavan1, Richa Lal, Sadiq S Sikora
1Department of Surgical Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014 UP, India.
Insights
Infantile choledochal cysts (CDCs) present differently and have poorer liver histology than classical pediatric CDCs. Early surgery is crucial for satisfactory outcomes in infants with CDCs.
Area of Science:
- Pediatric Surgery
- Hepatology
- Gastroenterology
Background:
- Choledochal cysts (CDCs) are congenital bile duct anomalies.
- Infantile CDCs present unique challenges compared to later-presenting pediatric cases.
Purpose of the Study:
- To compare clinical features, liver histology, and surgical outcomes of infantile CDCs versus classical pediatric CDCs.
- To inform optimal management strategies for infantile CDCs.
Main Methods:
- Retrospective analysis comparing 14 infants (<1 year) with 52 children (1-12 years) diagnosed with CDCs.
- Differentiation from biliary atresia using cholangiogram findings.
- Evaluation of clinical presentation, liver histology, and surgical outcomes.
Main Results:
- Jaundice was universal in infantile CDCs; 6 cases mimicked biliary atresia.
- Pancreatitis occurred exclusively in the classical pediatric group.
- 100% of infants showed fibrosis by 4 weeks; 7/9 had bridging fibrosis or cirrhosis. Outcomes were satisfactory in 64.3% of infants, even with advanced fibrosis.
Conclusions:
- Infantile CDCs have distinct clinical features, liver histology, and outcomes compared to classical pediatric CDCs.
- Emergent surgical treatment for infantile CDCs leads to satisfactory outcomes.
- Delayed treatment of infantile CDCs can result in end-stage liver disease.
Abstract:
The purpose of this analysis is to study the clinical features, liver histology and the outcome after surgery in infants with choledochal cysts (CDCs), and to draw conclusions on the management strategy accordingly. The clinical features, liver histology and the outcome after surgery in 14 cases of CDCs treated before 1 year of age (the "infantile group") were compared with 52 cases that were diagnosed and treated between 1 and 12 years of age (the "classical pediatric group"). The differentiation of the "infantile choledochal cysts" from "biliary atresia with cystic dilatation" was based on the configuration of intrahepatic bile ducts on cholangiogram. Jaundice was the universal presenting feature in 14 patients in the "infantile group", the clinical presentation in 6 infants was indistinguishable from biliary atresia. On the other hand, pancreatitis as a presenting complication was seen exclusively in those presenting later, i.e. the "classical pediatric group". Fibrosis, as early as 4 weeks of age, was seen in all nine (100%) infants in whom a liver histology was available. Seven of these nine infants had bridging fibrosis (n = 4) or cirrhosis (n = 3) on liver histology. The outcome was satisfactory in 9 of the 14 (64.3%) infants despite bridging fibrosis (n = 4) or cirrhosis (n = 1) in 5 of these 9 babies. The CDCs presenting in infancy differ from the classical variety of later presenting pediatric CDCs in terms of their presentation, liver histology and outcome. They merit an emergent surgical treatment following which the outcome is satisfactory. Delay results in progression to end stage liver disease.
Related Concept Videos
Cholecystitis
Endoscopic Procedures V: ERCP
Patient...